AstraZeneca gets EU backing for targeted breast cancer therapies

3 years ago 6
Breast cancer patients may now benefit from two of AstraZeneca's existing therapies. The EU has recommended lynparza and enhertu to treat high-risk breast cancer.
Read Entire Article